Thalidomide - Follow-up meeting with patients' and victims' organisations

• Date:
  Monday, 5 September 2011, All day
• Location:
  European Medicines Agency, Amsterdam, the Netherlands

This meeting provided an update on activities and the use of Thalidomide Celgene in the post-marketing phase to those patients' and thalidomide victims' organisations that were previously consulted during its initial marketing authorisation evaluation in 2007.

Documents

Minutes of thalidomide follow-up meeting with patients’ and victims’ organisations

Adopted Reference Number: EMA/743134/2011 Corr 2

Agenda – Thalidomide - Follow-up meeting with patients’ and victims’ organisations

Reference Number: EMA/540386/2011 Corr.